Stokes ESE - Search Results

1

An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies.

Morar-Mitrica S, Adams ML, Crotts G, Wurth C, Ihnat PM, Tabish T, Antochshuk V, DiLuzio W, Dix DB, Fernandez JE, Gupta K, Fleming MS, He B, Kranz JK, Liu D, Narasimhan C, Routhier E, Taylor KD, Truong N, Stokes ESE. Morar-Mitrica S, et al. Among authors: stokes ese. J Pharm Sci. 2018 Feb;107(2):529-542. doi: 10.1016/j.xphs.2017.10.017. Epub 2017 Oct 23. J Pharm Sci. 2018. PMID: 29074375

2

An Industry Perspective on Forced Degradation Studies of Biopharmaceuticals: Survey Outcome and Recommendations.

Halley J, Chou YR, Cicchino C, Huang M, Sharma V, Tan NC, Thakkar S, Zhou LL, Al-Azzam W, Cornen S, Gauden M, Gu Z, Kar S, Lazar AC, Mehndiratta P, Smith J, Sosic Z, Weisbach P, Stokes ESE. Halley J, et al. Among authors: stokes ese. J Pharm Sci. 2020 Jan;109(1):6-21. doi: 10.1016/j.xphs.2019.09.018. Epub 2019 Sep 26. J Pharm Sci. 2020. PMID: 31563512

3

An Industry Perspective on Compatibility Assessment of Closed System Drug-Transfer Devices for Biologics.

Besheer A, Burton L, Galas RJ Jr, Gokhale K, Goldbach P, Hu Q, Mathews L, Muthurania K, Narasimhan C, Singh SN, Stokes ESE, Weiser S, Zamiri C, Zhou S. Besheer A, et al. Among authors: stokes ese. J Pharm Sci. 2021 Feb;110(2):610-614. doi: 10.1016/j.xphs.2020.10.047. Epub 2020 Oct 28. J Pharm Sci. 2021. PMID: 33127425 Free article.

4

An Intercompany Perspective on Compatibility and In-use Stability Studies to Enable Administration Of Biopharmaceutical Drug Products.

Kamen DE, Crotts G, Narasimhan C, Hu Q, Bhargava AC, Muthurania K, Burton L, Gbormittah FO, Mathews L, Mills B, Hodge T, Saluja S, Singh SN, Tabish T, Wu Y, Stokes ESE. Kamen DE, et al. Among authors: stokes ese. J Pharm Sci. 2022 Apr;111(4):1092-1103. doi: 10.1016/j.xphs.2021.09.043. Epub 2021 Sep 30. J Pharm Sci. 2022. PMID: 34600941

5

An Intercompany Perspective on Practical Experiences of Predicting, Optimizing and Analyzing High Concentration Biologic Therapeutic Formulations.

Desai PG, Garidel P, Gbormittah FO, Kamen DE, Mills BJ, Narasimhan CN, Singh S, Stokes ESE, Walsh ER. Desai PG, et al. Among authors: stokes ese. J Pharm Sci. 2023 Feb;112(2):359-369. doi: 10.1016/j.xphs.2022.11.020. Epub 2022 Nov 25. J Pharm Sci. 2023. PMID: 36442683

6

An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals.

Campbell JM, Colombo S, Doyle JL, Filoti DI, Hübner G, Magnenat L, Nowinski AK, Pavon JA, Singh SM, Vo LR, Woods JM, Stokes ESE. Campbell JM, et al. Among authors: stokes ese. J Pharm Sci. 2024 Mar;113(3):505-512. doi: 10.1016/j.xphs.2023.12.011. Epub 2023 Dec 15. J Pharm Sci. 2024. PMID: 38103689

7

Best practices in bioassay development to support registration of biopharmaceuticals.

White JR, Abodeely M, Ahmed S, Debauve G, Johnson E, Meyer DM, Mozier NM, Naumer M, Pepe A, Qahwash I, Rocnik E, Smith JG, Stokes ES, Talbot JJ, Wong PY. White JR, et al. Biotechniques. 2019 Sep;67(3):126-137. doi: 10.2144/btn-2019-0031. Epub 2019 Aug 5. Biotechniques. 2019. PMID: 31379198 Free article.

8

An industry perspective approach and control strategy for implementation of ready-to-use cells in bioassays: survey outcome and recommendations.

White JR, Ahmed S, Amstrup J, Bennington P, Cheng ZJ, Day P, Haenssen KK, Kozminsky-Atias A, Martinez E, Ong EH, Qahwash I, Stokes ES, Wang J. White JR, et al. Biotechniques. 2024 Apr;76(4):135-144. doi: 10.2144/btn-2023-0086. Epub 2024 Feb 9. Biotechniques. 2024. PMID: 38334496 Free article.

9

Design and campaign synthesis of pyridine-based histone deacetylase inhibitors.

Andrews DM, Gibson KM, Graham MA, Matusiak ZS, Roberts CA, Stokes ES, Brady MC, Chresta CM. Andrews DM, et al. Bioorg Med Chem Lett. 2008 Apr 15;18(8):2525-9. doi: 10.1016/j.bmcl.2008.03.058. Epub 2008 Mar 22. Bioorg Med Chem Lett. 2008. PMID: 18378451

10

Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.

Andrews DM, Stokes ES, Carr GR, Matusiak ZS, Roberts CA, Waring MJ, Brady MC, Chresta CM, East SJ. Andrews DM, et al. Bioorg Med Chem Lett. 2008 Apr 15;18(8):2580-4. doi: 10.1016/j.bmcl.2008.03.041. Epub 2008 Mar 16. Bioorg Med Chem Lett. 2008. PMID: 18378449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page